Literature DB >> 16596010

Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.

Yuko Ishii1, Nahoko Shoji, Yukihiko Kimura, Kazuma Ohyashiki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16596010     DOI： 10.2169/internalmedicine.45.1602

Source DB:  PubMed          Journal:  Intern Med        ISSN： 0918-2918            Impact factor:   1.271


× No keyword cloud information.
  3 in total

1.  Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors.

Authors:  Biren Saraiya; Rashmi Chugh; Vassiliki Karantza; Janice Mehnert; Rebecca A Moss; Nelli Savkina; Mark N Stein; Laurence H Baker; Thomas Chenevert; Elizabeth A Poplin
Journal:  Invest New Drugs       Date:  2010-08-10       Impact factor: 3.850

Review 2.  Imatinib: in relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Authors:  Sarah A Cross; Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Imatinib-induced pleural effusion: A case report.

Authors:  R Banka; Z Udwadia
Journal:  J Postgrad Med       Date:  2017 Jan-Mar       Impact factor: 1.476
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.